期刊文献+

PTD-OD-HA融合蛋白对BALB/c裸鼠皮下K562细胞实体瘤的治疗作用 被引量:1

Curative Effect of PTD-OD-HA Fusion Protein on Subcutaneous Solid Tumor Caused by K562 Cells in Nude BALB/c Mice
原文传递
导出
摘要 目的观察PTD-OD-HA融合蛋白对BALB/c裸鼠皮下K562细胞实体瘤的治疗作用。方法采用皮下注射K562细胞的方法建立裸鼠皮下实体瘤模型,每两天向实体瘤中间部位多点注射200μl浓度为10 mg/ml的PTD-OD-HA融合蛋白,观察裸鼠瘤体生长情况;HE染色观察肿瘤组织病理学变化;TUNEL法和透射电镜观察肿瘤组织细胞的凋亡。结果经PTD-OD-HA治疗的肿瘤体积明显缩小;肿瘤组织切片经HE染色可见细胞核浓缩和细胞染色加深;TUNEL法和透射电镜检测可见肿瘤细胞发生了凋亡的改变。结论在BALB/c裸鼠体内,PTD-OD-HA融合蛋白具有抑制K562细胞增殖和促进其凋亡的作用。 Objective To observe the curative effect of PTD-OD-HA fusion protein on subcutaneous solid tumor caused by K562 cells in nude BALB / c mice.Methods Nude mouse model of subcutaneous solid tumor was established by injection s.c.with K562 cells.A portion of 200 μl of PTD-OD-HA fusion protein,at a concentration of 10 mg / ml,were injected into the middle part of tumors,at multiple sites,every 2 days.The tumors were observed for growth visually,for cell morphology by HE staining,and for cell apoptosis by TUNEL method and transmission electron microscopy.Results The sizes of tumors after treatment with PTD-OD-HA decreased significantly.HE staining showed that the nuclei were concentrated and the cells were stained darkly.TUNEL method and transmission electron microscopy showed apoptosis of the tumor cells.Conclusion PTD-OD-HA fusion protein inhibited the proliferation and promoted the apoptosis of K562 cells in nude BALB / c mice.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第8期945-947,共3页 Chinese Journal of Biologicals
基金 国家自然科学基金(30670901)
关键词 慢性粒细胞白血病 融合蛋白 BCR/ABL融合基因 小鼠 Chronic myeloid leukemia Fusion protein bcr / abl fusion gene Mouse nude
  • 相关文献

参考文献10

  • 1Melo JV, Deininger MW. Biology of chronic myelogenous leukemia-signaling pathways of initiation and transformation [J]. Hematol Oncol Clin North Am, 2004, 18 (3): 545-568.
  • 2Beissert T, Hundertmark A, Kaburova V, et al. Targeting of the N-terminal coiled coil oligomerization interface by a helix-2 peptide inhibits unmutated and imatinib-resistant BCR/ABL [J]. Int J Cancer, 2008, 122 (12) : 2744-2752.
  • 3黄峥兰,季茂胜,袁颖,黄世峰,刘钉宾,曾建明,温健萍,冯文莉.PTD-OD-HA融合蛋白对bcr/abl阳性细胞凋亡的影响[J].肿瘤,2010,30(4):267-271. 被引量:4
  • 4黄峥兰,季茂胜,袁颖,黄世峰,刘钉宾,曾建明,温健萍,冯文莉.PTD-OD-HA融合蛋白对BCR-ABL阳性细胞增殖的影响[J].解放军医学杂志,2010,35(7):849-852. 被引量:2
  • 5季茂胜,黄峥兰,黄世峰,曾建明,刘钉宾,罗红伟,曹唯希,冯文莉.慢性粒细胞白血病Bcr/Abl基因OD域融合蛋白的原核表达及纯化[J].中国生物制品学杂志,2010,23(4):354-357. 被引量:5
  • 6Koschmieder S, Gottgens B, Zhang P, et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stein cells in a transgenic model of BCR-ABL leukemogenesis [J]. Blood, 2005, 105 ( 1 ): 324-334.
  • 7Zhao Z, Tang X, You Y, et al. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia [J]. Leuk Res, 2006, 30 (8): 993-1003.
  • 8Druker BJ. Translation of the Philadelphia chromosome into therapy for CML [J]. Blood, 2008, 112 (13): 4808-4817.
  • 9Song EY, Palladineni P, Klamer G, et al. Glycogen synthase kinase-3β inhibitors suppress leukemia cell growth [J]. Exp Hematol, 2010, 38 (10): 908-921.
  • 10Shi X, Jin Y, Cheng C, et al. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in ST1571-resistant chronic myelogenous leukemia cells harboring T315I mutation [J]. Clin Cancer Res, 2009, 15 (5): 1686-1697.

二级参考文献34

  • 1Schembri L, Dalibart R, Tomasello F, et al. The HA tag is cleaved and loses immunoreaetivity during apoptosis. Nat Methods, 2007, 4 (2): 107-108.
  • 2Wadia JS, Dowdy SF. Transroembrane delivery of protein and peptide drugs by TAT-roediated transduction in the treatment of cancer. Adv Drag Deliv Rev, 2005, 57 (4): 579-596.
  • 3Zhao X, Ghaffari S, Lodish H, et al. Structure of the Bcr-Abl oncoprotein oligomerization domain. Nat Struct Biol, 2002, 9 (2): 117- 120.
  • 4Beissert T, Hundertmark A, Kaburova V, et al. Targeting of the N- terminal coiled coil oligomerization interface by a helix-2 peptide inhibits unmutated and imatinib-resistant BCR/ABL. Int J Cancer, 2008, 122 ( 12): 2744-2752.
  • 5Beissert T, Puccctti E, Bianehini A ,et al. Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571. Blood, 2003, 102 (8): 2985-2993.
  • 6Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein transduction into mammalian cells. Methods, 2001, 24 (3): 247- 256.
  • 7Kang CS, Son SY, Bang IS. Biologically active and C-amidated hinnavinII-38-Asn produced from a Trx fusion construct in Escherichia coli. J Microbiol, 2008, 46 (6): 656-661.
  • 8Hedhammar M, Graslund T, Hober S. Protein engineering strategies for selective protein purification. Chem Eng Teehnol, 2005, 28 (11): 1315-1325.
  • 9Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood, 2008, 112 (13): 4808-4817.
  • 10Quintas-Cardama A, Cortes J. Molecular biology of ber-abll positive chronic myeloid leukemia. Blood, 2009, 113 (8): 1619-1630.

共引文献6

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部